Division of Orthopaedic Oncology, Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Orthopaedic Surgery, The Medical University of South Carolina, Charleston, South Carolina.
J Bone Joint Surg Am. 2023 Jul 19;105(Suppl 1):34-40. doi: 10.2106/JBJS.22.01185.
Surgical site infections (SSIs) represent a major complication following oncologic reconstructions. Our objectives were (1) to assess whether the use of postoperative drains and/or negative pressure wound therapy (NPWT) were associated with SSIs following lower-extremity oncologic reconstruction and (2) to identify factors associated with the duration of postoperative drains and with the duration of NPWT.
This is a secondary analysis of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) trial, a multi-institution randomized controlled trial of lower-extremity oncologic reconstructions. Data were recorded regarding the use of drains alone, NPWT alone, or both NPWT and drains, including the total duration of each postoperatively. We analyzed postoperative drain duration and associations with tourniquet use, intraoperative thromboprophylaxis or antifibrinolytic use, incision length, resection length, and total operative time, through use of a linear regression model. A Cox proportional hazards model was used to evaluate the independent predictors of SSI.
Overall, 604 patients were included and the incidence of SSI was 15.9%. Postoperative drains alone were used in 409 patients (67.7%), NPWT alone was used in 15 patients (2.5%), and both postoperative drains and NPWT were used in 68 patients (11.3%). The median (and interquartile range [IQR]) duration of drains and of NPWT was 3 days (IQR, 2 to 5 days) and 6 days (IQR, 4 to 8 days), respectively. The use of postoperative drains alone, NPWT alone, or both drains and NPWT was not associated with SSI (p = 0.14). Increased postoperative drain duration was associated with longer operative times and no intraoperative tourniquet use, as shown on linear regression analysis (p < 0.001 and p = 0.03, respectively). A postoperative drain duration of ≥14 days (hazard ratio [HR], 3.6; 95% confidence interval [CI], 1.3 to 9.6; p = 0.01) and an operative time of ≥8 hours (HR, 4.5; 95% CI, 1.7 to 11.9; p = 0.002) were independent predictors of SSI following lower-extremity oncologic reconstruction.
A postoperative drain duration of ≥14 days and an operative time of ≥8 hours were independent predictors of SSI following lower-extremity oncologic reconstruction. Neither the use of postoperative drains nor the use of NPWT was a predictor of SSI. Future research is required to delineate the association of the combined use of postoperative drains and NPWT with SSI.
Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.
手术部位感染(SSI)是肿瘤重建术后的主要并发症。我们的目的是:(1)评估下肢肿瘤重建术后使用术后引流管和/或负压伤口治疗(NPWT)是否与 SSI 相关;(2)确定与术后引流管持续时间和 NPWT 持续时间相关的因素。
这是肿瘤手术预防性抗生素方案(PARITY)试验的二次分析,这是一项多机构下肢肿瘤重建的随机对照试验。记录了单独使用引流管、单独使用 NPWT 或同时使用 NPWT 和引流管的数据,包括术后的总持续时间。我们通过线性回归模型分析术后引流管持续时间与止血带使用、术中血栓预防或抗纤维蛋白溶解药物使用、切口长度、切除长度和总手术时间的关系。使用 Cox 比例风险模型评估 SSI 的独立预测因素。
共有 604 例患者纳入研究,SSI 发生率为 15.9%。409 例患者(67.7%)单独使用术后引流管,15 例(2.5%)单独使用 NPWT,68 例(11.3%)同时使用术后引流管和 NPWT。引流管和 NPWT 的中位(四分位距)持续时间分别为 3 天(2 至 5 天)和 6 天(4 至 8 天)。单独使用术后引流管、单独使用 NPWT 或同时使用引流管和 NPWT 均与 SSI 无关(p=0.14)。线性回归分析显示,术后引流管持续时间增加与手术时间延长和术中不使用止血带有关(p<0.001 和 p=0.03)。术后引流管持续时间≥14 天(风险比[HR],3.6;95%置信区间[CI],1.3 至 9.6;p=0.01)和手术时间≥8 小时(HR,4.5;95%CI,1.7 至 11.9;p=0.002)是下肢肿瘤重建术后 SSI 的独立预测因素。
术后引流管持续时间≥14 天和手术时间≥8 小时是下肢肿瘤重建术后 SSI 的独立预测因素。术后引流管和 NPWT 的使用均不是 SSI 的预测因素。需要进一步研究来阐明术后引流管和 NPWT 联合使用与 SSI 的关系。
治疗性 II 级。有关证据水平的完整描述,请参见作者指南。